Health AI Central
Share:
Peer-Reviewed Publication
Value Health Reg Issues2026;101659.June 17, 2026Journal Article

Economic Evaluation of the Use of Artificial Intelligence in Stress Echocardiography: Cost-Consequence and Cost-Effectiveness Analysis.

Ankur S Chauhan1, Ashley Akerman2, Ross Upton3, Paul Leeson4, Gary Woodward2, James Rose5, Mamta Bajre5
1Health Innovation Oxford and Thames Valley, NHS England, Oxford, England, UK. Electronic address: ankur.chauhan@healthinnovationoxford.org.
2Ultromics Ltd, Oxford, England, UK.
3Ultromics Ltd, Oxford, England, UK; Cardiovascular Clinical Research Facility, RDM Division of Cardiovascular Medicine, University of Oxford, Oxford, England, UK.
4Cardiovascular Clinical Research Facility, RDM Division of Cardiovascular Medicine, University of Oxford, Oxford, England, UK.
5Health Innovation Oxford and Thames Valley, NHS England, Oxford, England, UK.
PubMed DOI

Abstract

OBJECTIVES: To assess the economic impact of Artificial Intelligence (AI)-assisted stress echocardiography (SE) in the National Health Service (NHS) diagnostic pathway for coronary artery disease (CAD) using cost-effectiveness analysis and cost-consequence analysis alongside a multicenter randomized controlled trial. METHODS: This evaluation was embedded in the PROTEUS trial, a 20-hospital NHS ra…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.